AI
PRCT icon

Atom Investors’s Procept Biorobotics PRCT Stock Holding History

Atom Investors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Buy
15,807
+4,222
+36% +$119K 0.03% 512
2025
Q4 		$364K Sell
11,585
-11,171
-49% -$370K 0.03% 424
2025
Q3 		$812K Buy
+22,756
New +$1.04M 0.06% 279
2022
Q4 		– Sell
-12,686
Closed -$526K – 299
2022
Q3 		$526K Sell
12,686
-2,024
-14% -$80.7K 0.19% 148
2022
Q2 		$481K Buy
+14,710
New +$535K 0.21% 117

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atom Investors's PRCT Position: Q1 2026 in Review

Atom Investors increased its Procept Biorobotics (PRCT) stake by 36% in Q1 2026, buying an estimated $119K and bringing the position to 15,807 shares worth $395K. The position accounts for 0.03% of the portfolio, ranked #512.

Atom Investors first reported a position in PRCT in Q2 2022 and has held it in 5 quarters since. The position peaked at $812K in Q3 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Atom Investors held 15,807 shares of Procept Biorobotics worth $395K as of Q1 2026.
  • Atom Investors bought 4,222 Procept Biorobotics shares in Q1 2026, an estimated $119K.
  • Procept Biorobotics made up 0.03% of Atom Investors's portfolio in Q1 2026, its #512 holding.
  • Atom Investors first reported a position in Procept Biorobotics in Q2 2022 and has held it in 5 quarters since.
  • Atom Investors's Procept Biorobotics position peaked at $812K in Q3 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.